2011 News

December 2, 2011

Morphotek Terminates Farletuzumab Study (FAR 122) in Platinum-Resistant Ovarian Cancer
Read More

June 28, 2011

Morphotek, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
Read More

June 27, 2011

Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food For Local Families
Read More

April 27, 2011

Precis Engineering Provides MEP Engineering, Commissioning for Morphotek Pilot Plant
Read More

April 12, 2011

Morphotek Receives Grant to Support Development of Therapeutic Antibodies Against Biowarfare Agents
Read More

April 6, 2011

Morphotek, Inc. Receives Beacon Award From CancerCare
Read More

April 4, 2011

Morphotek, Inc. Announces Acquisition of Tumor Targeting Assets from Transmolecular, Inc.
Read More

March 29, 2011

Morphotek, Inc. Announces an Agreement With Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit For Detection of Folate Receptor Alpha in Malignant Tissues
Read More